In addition to its role in HF, CaMKII has been associated with the development of arrhythmias and there are already several CaMKII inhibitors preclinically tested as antiarrhythmic drugs (Lebek et al., 2018; Neef et al., 2018). Here, CAMK2G is linked to cardiac arrhythmia.